Cheshire-based research organisation drives business growth with expansion of services

Leading contract research organisation (CRO), Gentronix, based at Alderley Park in Cheshire, has introduced a new service range in response to increasing global demand, driving further growth for the business.

The CRO has added a new service capability to its expanding toxicology offering, the 96-Well MNT with automated slide scoring. The new assay will enable Gentronix to provide faster turnaround times, allowing rapid project decision-making with minimal compound requirements.

Automated scoring results in faster delivery of data than manual slide scoring methods, allowing for quicker delivery of project timelines. This new service will strengthen Gentronix’ ability to support clients in meeting their deadlines, identifying potential hazards and manage risk for their materials.

The addition to Gentronix’s portfolio comes shortly after the company announced a further laboratory and office expansion at its home at Alderley Park in April, as part of the firm’s ongoing growth plans.

The previous expansions have accommodated increased capacity for its genetic toxicology screening services and genetic, ocular, and skin toxicology testing - growing the Gentronix footprint at Alderley Park by 30 per cent.

Matt Tate, CEO at Gentronix said: “We are committed to providing the highest quality science for our expanding global client base. By adding the 96-Well MNT with automated slide scoring to our service capabilities, it will enable us to deliver even faster turnaround times for our clients and their projects.

“We are continuing our business growth journey this year and have already invested considerable effort into expanding our facilities and capacity and creating more high-quality jobs for the UK life science sector.”

By Mark Adair – Correspondent, Bdaily

• Add me on LinkedIn and Twitter to keep up to date
• And follow Bdaily on Facebook, Twitter and LinkedIn
• Submit press releases to editor@bdaily.co.uk for consideration.